Small Cap Active Runners: IAMGOLD (NYSE:IAG), Trina Solar (NYSE:TSL), AK Steel Holding Corporation (NYSE:AKS), The Medicines Company (NASDAQ:MDCO)

IAMGOLD Corporation (USA) (NYSE:IAG) announced that a Form 40-F report has been filed with the U.S. Securities and Exchange Commission, consisting of the 2013 annual audited financial statements, management discussion and analysis and the annual information form (‘AIF”). IAMGOLD Corp (USA) (NYSE:IAG) stock performance was -2.27% in last session and finished the day at $3.44. Traded volume was 5.83million shares in the last session and the average volume of the stock remained 6.61million shares. The beta of the stock remained 0.58.

Trina Solar Limited (ADR) (NYSE:TSL) producing just 400MW less than Yingli in 2013 and taking 8.2 per cent of the market, said GlobalData. Trina Solar Limited (ADR) (NYSE:TSL) rose 7.88 percent to $14.51 Tuesday on volume of 5.74million shares. The intra-day range of the stock was $13.60 to $14.51. Trina Solar Limited (ADR) (NYSE:TSL) has a market capitalization of $1.16billion.

American producer of stainless and low carbon steel, AK Steel Holding Corporation (NYSE:AKS) is known for its innovative products. For being ahead of its competitors, it has launched shuffle in prices of its products. The effect of the same is not significant enough to be calculated. However, with more dealings and agreements, the scenario would be clear for analysis. AK Steel Holding Corporation (NYSE:AKS)’s stock on Apr 01, 2014 reported a increase of 1.94% to the closing price of $7.36. Its fifty two weeks range is $2.76 -$8.47. The total market capitalization recorded $1.01billion. The overall volume in the last trading session was 8.06million shares. In its share capital, AKS has 136.68million outstanding shares.

Shares of The Medicines Company (NASDAQ:MDCO) have been given a consensus recommendation of “Hold” by the nine ratings firms that are currently covering the company, reports. One analyst has rated the stock with a sell rating, four have given a hold rating and four have given a buy rating to the company. On Tuesday, shares of The Medicines Company (NASDAQ:MDCO) dropped -15.48% to close the day at $24.02. Company return on investment (ROI) is 1.00% and its monthly performance is recorded as -20.12%. The Medicines Company (NASDAQ:MDCO) quarterly revenue growth is -37.72%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone